Feb 18, 2009
By:
George Koroneos, Online Content & News Editor
Two pharma companies dabble in online video in two different but effective ways. Sanofi-aventis attempts to reach patients through educational videos, while AZ calls for consumers to upload their own testimonials.
|
Feb 18, 2009
By:
George Koroneos, Online Content & News Editor
FDA reprimanded Bayer for running misleading advertising touting unproven benefits of the contraceptive Yaz. Now the drug company will shell out $20 million for new ads setting the record straight.
|
Feb 4, 2009
By:
George Koroneos, Online Content & News Editor
Pfizer switched agencies for its popular smoking cessation drug Chantix. While the company is tight lipped about the campaign's new direction, it looks like this may be the end of the tortoise and hare. Does this signal an end to the use of critters in pharma ads?
|
Feb 4, 2009
By:
George Koroneos, Online Content & News Editor
Pharma companies are trimming their bloated sales forces by the hundreds. Eyeballing a golden opportunity, Publicis has aligned its independent communications and sales shops under one umbrella, giving pharma a one-stop-shop for filling in sales gaps. Pharm Exec talks to Publicis? Betsy Lane to learn more.
|
Jan 28, 2009
By:
George Koroneos, Online Content & News Editor
Big name patent expirations may be looming, but that's not stopping pharma companies from filing - and getting approved for - dozens of new patents. Pharm Exec looks at which companies are getting the most approvals, and how 2008 compared to previous years.
|
Jan 28, 2009
By:
George Koroneos, Online Content & News Editor
Pfizer hit hard with the surprise purchase of Wyeth. But will the pharma giant strike out in the long run? Analysts ponder the long and short-term ramifications of this monster acquisition.
|
Jan 21, 2009
By:
George Koroneos, Online Content & News Editor
A new study suggests the medical professionals are more active on social networking sites than ever before. With the rise of doctor-specific Web 2.0 outlets, pharma has a new tool for reaching elusive physicians. The best part: Doctors don?t seem to mind.
|
|
PharmExec Blog
Follow Us
RSS
Bookstore
